Atu Agawu

Dr. Atu Agawu

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2012 in Nature Materials
Verified
Journal Article
Closed access
PDF file
JPJason Park
Jason Park
SWStephen H. Wrzesinski
Stephen H. Wrzesinski
ESEric Stern
Eric Stern
MLMichael Look
Michael Look
JCJason Criscione
Jason Criscione
TFTarek M. Fahmy
Tarek M. Fahmy

1 January 2012 in Acta Biomaterialia
Verified
Journal Article
Closed access
TSTimothy D. Sargeant
Timothy D. Sargeant
ADArpan P. Desai
Arpan P. Desai
SBSaumya Banerjee
Saumya Banerjee
AAAtu Agawu
Atu Agawu
JSJoshua B. Stopek
Joshua B. Stopek

1 November 2020 in The Journal of Pediatrics
Verified
Journal Article
Closed access
BCBarbara H. Chaiyachati
Barbara H. Chaiyachati
AAAtu Agawu
Atu Agawu
JZJoseph J. Zorc
Joseph J. Zorc
FBFran Balamuth
Fran Balamuth

1 November 2011 in Journal of Controlled Release
Verified
Journal Article
Closed access
JPJason Park
Jason Park
TMThomas Mattessich
Thomas Mattessich
SJSteven Jay
Steven Jay
AAAtu Agawu
Atu Agawu
WSW. Mark Saltzman
W. Mark Saltzman
TFTarek M. Fahmy
Tarek M. Fahmy

1 October 2016 in Advances in Radiation Oncology
Verified
Journal Article
Open access
AAAyobami Ajayi
Ayobami Ajayi
WHWei-Ting Hwang
Wei-Ting Hwang
NVNeha Vapiwala
Neha Vapiwala
MRMark Rosen
Mark Rosen
CCChristina H. Chapman
Christina H. Chapman
CDCurtiland Deville
Curtiland Deville
There is growing evidence supporting incorporating multiparametric (mp) magnetic resonance imaging (MRI) scans into risk stratification, active surveillance, and treatment paradigms for prostate cancer. The purpose of our study was to determine whether demographic disparities exist in staging MRI utilization for prostate cancer patients. An institutional database of 705 nonmetastatic prostate cancer patients treated with radiation therapy from 2005 through 2013 was used to identify patients undergoing versus not undergoing pretreatment diagnostic prostate mpMRI. Uni- and multivariable logistic regression evaluated the relationship of clinical and demographic characteristics with MRI utilization. All demographic variables assessed, except the other race category, were significantly associated with MRI utilization (all P < .05), including age (odds ratio [OR], 0.92), black race (OR, 0.51), poverty (OR, 0.53), closer distance to radiation facility (OR, 1.79), and nonprivate primary insurance (OR, 0.57) on univariable analysis, while clinical stage T3 (OR, 3.37) was the only clinical characteristic. On multivariable analysis stratified by D'Amico risk group, age remained significant across all risk groups, whereas the black versus white racial (OR, 0.21; 95% confidence interval, 0.08-0.55) and nonprivate versus private insurance type (OR, 0.37; 95% confidence interval, 0.16-0.86) disparities persisted in the low-risk group. Clinical stage T3 remained associated in the high-risk group. For race specifically, the percentages of whites, blacks, and others undergoing MRI in the overall cohort and by risk group were, respectively: overall, 80% (343/427), 68% (156/231), and 85% (40/47); low risk, 86%, 56%, and 63%; intermediate risk, 79%, 72%, and 95%; and high risk, 72%, 72%, and 100%. In this urban, academic center cohort, older patients across all risk groups and black or nonprivate insurance patients in the low risk group were less likely to undergo staging prostate MRI scans. Further research should investigate these differences to ensure equitable utilization across all demographic groups considering the burden of prostate cancer disparities.

1 May 2023 in JAMA Pediatrics
Verified
Journal Article
Closed access
PDF file
AAAtu Agawu
Atu Agawu
BCBarbara H. Chaiyachati
Barbara H. Chaiyachati
JRJoshua Radack
Joshua Radack
ADAndrea F. Duncan
Andrea F. Duncan
AEAngela Ellison
Angela Ellison
This cross-sectional study sought to quantify the frequency of change in race category in the electronic medical record (EMR) of a pediatric population.